Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12615001282572Phase 2Completed
Phase 2, randomised, open-label trial of hypertonic saline in acute respiratory distress syndrome (ARDS), sponsored by Shailesh Bihari. Primary endpoint: Composite clinical improvement endpoint. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12615001282572.